These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 33090197)
1. The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture. Sachithanandham J; Thio CL; Balagopal A Clin Infect Dis; 2021 Nov; 73(9):e2943-e2945. PubMed ID: 33090197 [No Abstract] [Full Text] [Related]
2. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278 [TBL] [Abstract][Full Text] [Related]
3. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Bölke E; Matuschek C; Fischer JC N Engl J Med; 2020 Oct; 383(17):1694-1695. PubMed ID: 32966710 [No Abstract] [Full Text] [Related]
4. Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City. Green NS; Van Doren L; Licursi M; Billings DD; Sandoval LA; Feit YMZ; Hod EA Br J Haematol; 2022 Aug; 198(4):680-683. PubMed ID: 35759223 [No Abstract] [Full Text] [Related]
5. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply. Yang OO; Ibarrondo FJ N Engl J Med; 2020 Oct; 383(17):1697-1698. PubMed ID: 32966713 [No Abstract] [Full Text] [Related]
6. Natural Antibodies and Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Healthy Asymptomatic Individuals. Steele EJ; Gorczynski RM; Lindley RA; Chandra Wickramasinghe N Clin Infect Dis; 2023 May; 76(9):1697. PubMed ID: 36623174 [No Abstract] [Full Text] [Related]
7. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645 [TBL] [Abstract][Full Text] [Related]
8. SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality. Kelleni MT J Infect; 2021 Feb; 82(2):e35. PubMed ID: 32810520 [No Abstract] [Full Text] [Related]
9. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma. Lindholm PF; Ramsey G; Kwaan HC Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774 [TBL] [Abstract][Full Text] [Related]
10. Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells. Lau SKP; Wong ACP; Luk HKH; Li KSM; Fung J; He Z; Cheng FKK; Chan TTY; Chu S; Aw-Yong KL; Lau TCK; Fung KSC; Woo PCY Emerg Infect Dis; 2020 Dec; 26(12):2961-2965. PubMed ID: 32730733 [TBL] [Abstract][Full Text] [Related]
11. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127 [TBL] [Abstract][Full Text] [Related]
12. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2. Chouchane L; Grivel JC; Farag EABA; Pavlovski I; Maacha S; Sathappan A; Al-Romaihi HE; Abuaqel SW; Ata MMA; Chouchane AI; Remadi S; Halabi N; Rafii A; Al-Thani MH; Marr N; Subramanian M; Shan J JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33529170 [TBL] [Abstract][Full Text] [Related]
13. Serological differentiation between COVID-19 and SARS infections. Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906 [TBL] [Abstract][Full Text] [Related]
14. Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2? Soong D; Leeman R; Pillai A Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32620562 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future]. Ye ZW; Jin DY Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053 [TBL] [Abstract][Full Text] [Related]
17. Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients". Li YC; Bai WZ; Hashikawa T J Med Virol; 2020 Jul; 92(7):707-709. PubMed ID: 32246783 [TBL] [Abstract][Full Text] [Related]
18. The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response. Zhang Y; Li D; Zhao H; Wang L; Liao Y; Li X; Mou T; Li Q Vaccine; 2021 Apr; 39(18):2500-2503. PubMed ID: 33814228 [No Abstract] [Full Text] [Related]
19. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Khare P; Sahu U; Pandey SC; Samant M Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476 [TBL] [Abstract][Full Text] [Related]
20. Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays. Yamaoka Y; Jeremiah SS; Miyakawa K; Saji R; Nishii M; Takeuchi I; Ryo A Clin Infect Dis; 2021 Apr; 72(7):1291-1292. PubMed ID: 32445559 [No Abstract] [Full Text] [Related] [Next] [New Search]